Dr. Mark Sawicki has been named chief business officer of Cambridge Major Laboratories, Inc. (CML). With executive leadership responsibility for the global sales and marketing organization, Dr. Sawicki will focus on developing strategies and managing their execution to drive topline performance and P&L growth, as well as hold primary responsibility for all partnership opportunities in alignment with CML’s overall strategic vision.
Dr. Sawicki has more than 15 years of life science experience, holding leadership positions and building sales and marketing operations in global environments. He previously held the roles of global vice president, Business Development at CMC Biologics, and vice president, Business Development – Europe at AMRI.
“Mark brings a strong track record of driving top line results and the proven ability to build world class sales and marketing organizations,” said Brian Scanlan, President and CEO of CML. “His experience driving positive outcomes for clients with projects that span from early development through commercialization was an important consideration,” said Scanlan. “As CML continues on a high growth trajectory, it is imperative that our organization be positioned for sustained growth globally; Mark will lead the efforts to ensure we are aligned across all geographies and service offerings, to position CML for continued growth.”